Evidence map›Paper›PMID 40649756›Full record

ArticleInternational journal of molecular sciences2025

Tracking Drug Resistance in

Rebecca de Abreu-Fernandes, Lucas Tavares de Queiroz, Natália Ketrin Almeida-de-Oliveira, Aline Rosa de Lavigne Mello, Jacqueline de Aguiar Barros, Lilian Rose Pratt-Riccio, Gisely Cardoso de Melo, Patrícia Brasil, Cláudio Tadeu Daniel-Ribeiro, Didier Menard and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Molecular Surveillance ofPathogens (Basel, Switzerland) · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rebecca de Abreu-FernandesLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21041-361, Brazil.
Lucas Tavares de QueirozLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21041-361, Brazil.
Natália Ketrin Almeida-de-OliveiraLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21041-361, Brazil.ORCID 0000-0002-3944-0439
Aline Rosa de Lavigne MelloLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21041-361, Brazil.
Jacqueline de Aguiar BarrosLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21041-361, Brazil.ORCID 0000-0002-8999-1722
Lilian Rose Pratt-RiccioLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21041-361, Brazil.ORCID 0000-0003-4002-5889
Gisely Cardoso de MeloFundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), Manaus 69040-000, Brazil.ORCID 0000-0002-8155-6005
Patrícia BrasilCentro de Pesquisa, Diagnóstico e Treinamento em Malária (CPD-Mal), Reference Laboratory for Malaria in the Extra-Amazonian Region for the Brazilian Ministry of Health, Secretaria de Vigilância Sanitária & Fiocruz, Rio de Janeiro 21041-361, Brazil.ORCID 0000-0001-9555-7976
Cláudio Tadeu Daniel-RibeiroLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21041-361, Brazil.
Didier MenardMalaria Parasite Biology and Vaccines Unit, Institut Pasteur, Université Paris Cité, F-75015 Paris, France.ORCID 0000-0003-1357-4495
Maria de Fátima Ferreira-da-CruzLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21041-361, Brazil.ORCID 0000-0003-3522-3792

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 306025/2018-3Conselho Nacional de Desenvolvimento Científico e Tecnológico 310445/2017- 5Conselho Nacional de Desenvolvimento Científico e Tecnológico 311562/2021-3Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado de Rio de Janeiro E-26/200.925/2022Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado de Rio de Janeiro E-26/202.921/2018Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado de Rio de Janeiro E-26/203.295/2015Fundação Oswaldo Cruz 026-FIO-18-2-1
6 · The paper itself

Abstract

Malaria remains a health problem, with

Indexed as

Drug ResistanceMalaria, FalciparumPlasmodium falciparumAntimalarialsArtemisininsATP-Binding Cassette, Sub-Family C ProteinsBrazilGenetic VariationHaplotypesHumansLinkage DisequilibriumMembrane Transport ProteinsMutationPolymorphism, Single NucleotideProtozoan ProteinsAntimalarialsArtemisininsATP-Binding Cassette, Sub-Family C ProteinsMdr1 protein, Plasmodium falciparumMembrane Transport ProteinsPfCRT protein, Plasmodium falciparumProtozoan Proteinsantimalarial drugsBrazilian endemic areasPlasmodium falciparumresistance

Identifiers

PMID40649756
PMCPMC12249875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.